Business Description
Beijing Hotgen Biotech Co Ltd
ISIN : CNE100003P82
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 54.26 | |||||
Equity-to-Asset | 0.96 | |||||
Debt-to-EBITDA | -0.11 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 26.14 | |||||
Beneish M-Score | -3.26 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.2 | |||||
3-Year EBITDA Growth Rate | -17.7 | |||||
3-Year FCF Growth Rate | -298.9 | |||||
3-Year Book Growth Rate | 65.3 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 56.84 | |||||
9-Day RSI | 60.65 | |||||
14-Day RSI | 62.7 | |||||
6-1 Month Momentum % | 115.56 | |||||
12-1 Month Momentum % | 44 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.85 | |||||
Quick Ratio | 8.95 | |||||
Cash Ratio | 3.58 | |||||
Days Inventory | 169.56 | |||||
Days Sales Outstanding | 41.54 | |||||
Days Payable | 140.56 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.29 | |||||
Forward Dividend Yield % | 0.29 | |||||
5-Year Yield-on-Cost % | 0.29 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 0.59 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 48.02 | |||||
Operating Margin % | -18.3 | |||||
Net Margin % | -13 | |||||
FCF Margin % | 9.81 | |||||
ROE % | -2.05 | |||||
ROA % | -1.94 | |||||
ROIC % | -3.54 | |||||
3-Year ROIIC % | -4.42 | |||||
ROC (Joel Greenblatt) % | -5.03 | |||||
ROCE % | -2.33 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 12.21 | |||||
PB Ratio | 1.99 | |||||
Price-to-Tangible-Book | 2.02 | |||||
Price-to-Free-Cash-Flow | 122.51 | |||||
Price-to-Operating-Cash-Flow | 20.92 | |||||
EV-to-EBIT | -77.18 | |||||
EV-to-EBITDA | -77.18 | |||||
EV-to-Revenue | 11.51 | |||||
EV-to-FCF | 111.58 | |||||
Price-to-Projected-FCF | 0.86 | |||||
Price-to-Net-Current-Asset-Value | 5.83 | |||||
Price-to-Net-Cash | 21.02 | |||||
Earnings Yield (Greenblatt) % | -1.3 | |||||
FCF Yield % | 0.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Beijing Hotgen Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 520.497 | ||
EPS (TTM) (Â¥) | -0.74 | ||
Beta | 1.74 | ||
Volatility % | 88.99 | ||
14-Day RSI | 62.7 | ||
14-Day ATR (Â¥) | 5.529843 | ||
20-Day SMA (Â¥) | 63.6215 | ||
12-1 Month Momentum % | 44 | ||
52-Week Range (Â¥) | 22.94 - 80.9 | ||
Shares Outstanding (Mil) | 92.47 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Beijing Hotgen Biotech Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Beijing Hotgen Biotech Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Beijing Hotgen Biotech Co Ltd Frequently Asked Questions
What is Beijing Hotgen Biotech Co Ltd(SHSE:688068)'s stock price today?
When is next earnings date of Beijing Hotgen Biotech Co Ltd(SHSE:688068)?
Does Beijing Hotgen Biotech Co Ltd(SHSE:688068) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |